EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries

Mike Du, Francesco Dernie, Martí Català, Antonella Delmestri, Wai Yi Man, James T Brash, Hanne van Ballegooijen, Núria Mercadé-Besora, Talita Duarte-Salles, Miguel-Angel Mayer, Angela Leis, Juan Manuel Ramírez-Anguita und 10 weitere

European Journal of Internal Medicine · 2024

DOI: 10.1016/j.ejim.2024.08.008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Mike Du und 21 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Glucocorticoids, Hydroxychloroquine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Multiple treatment options are recommended for Systemic Lupus Erythematosus (SLE) by clinical guidelines. This study aimed to explore SLE treatment patterns as there is limited real-world data of SLE medication utilisation, especially in childhood-onset SLE (cSLE). METHODS: We conducted a longitudinal cohort study using five routinely collected healthcare databases from four European countries (United Kingdom, France, Germany, and Spain). We described the characteristics of adult and paediatric patients at time of SLE diagnosis. We calculated the percentage of patients commencing SLE treatments in the first month and year after diagnosis, reported number of prescriptions, starting dose, cumulative dose, and duration of each treatment, and characterised the line of therapy. RESULTS: We characterised 11,255 patients with a first diagnosis of SLE and included 5718 in our medication utilisation analyses. The majority of adult SLE patients were female (range 80-88 %), with median age of 49 to 54 years at diagnosis. In the paediatric cohort (n = 378), 66-83 % of SLE patients were female, with median age of 12 to 16 years at diagnosis. Hydroxychloroquine and glucocorticoids were common first-line treatments in both adults and children, with second-line treatments including mycophenolate mofetil and methotrexate. Few cases of monoclonal antibody use were seen in either cohort. Initial glucocorticoid dosing in paediatric patients was often higher than in adults. CONCLUSION: Treatment choices for adult SLE patients across four European countries were in line with recent therapeutic consensus guidelines. High glucocorticoid prescriptions in paediatric patients suggests the need for steroid-sparing treatment alternatives and paediatric specific guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicGlucocorticoidsHydroxychloroquineHumansFemaleMaleChildAdolescentAdultLongitudinal StudiesMiddle AgedFranceImmunosuppressive AgentsMethotrexateGermanySpainEuropePractice Patterns, Physicians'Mycophenolic AcidYoung AdultUnited KingdomAntirheumatic AgentsAntibodies, Monoclonal

Stichwörter der Autor:innen

Drug utilisationEpidemiologyLupusReal world evidenceSystemic lupus erythematosus

Substanzen

GlucocorticoidsHydroxychloroquineImmunosuppressive AgentsMethotrexateMycophenolic AcidAntirheumatic AgentsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK.
  • Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK; Medical Sciences Division, University of Ox…
  • IQVIA, Real World Solutions, Brighton, UK.
  • IQVIA Solutions B.V, Amsterdam, the Netherlands.
  • Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Nether…

Zitieren

APA

Du, M., Dernie, F., Català, M., Delmestri, A., Man, W. Y., Brash, J. T., van Ballegooijen, H., Mercadé-Besora, N., Duarte-Salles, T., Mayer, M. A., Leis, A., Ramírez-Anguita, J. M., Griffier, R., Verdy, G., Prats-Uribe, A., Pacurariu, A., Morales, D. R., De Lisa, R., Galluzzo, S., …, & Tan, E. H. (2024). Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.08.008

Vancouver

Du M, Dernie F, Català M, Delmestri A, Man WY, Brash JT, et al. Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.08.008

BibTeX
@article{Du2024,
  author = {Du, Mike and Dernie, Francesco and Català, Martí and Delmestri, Antonella and Man, Wai Yi and Brash, James T and van Ballegooijen, Hanne and Mercadé-Besora, Núria and Duarte-Salles, Talita and Mayer, Miguel-Angel and Leis, Angela and Ramírez-Anguita, Juan Manuel and Griffier, Romain and Verdy, Guillaume and Prats-Uribe, Albert and Pacurariu, Alexandra and Morales, Daniel R and De Lisa, Roberto and Galluzzo, Sara and Egger, Gunter F and Prieto-Alhambra, Daniel and Tan, Eng Hooi},
  title = {Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries},
  journal = {European Journal of Internal Medicine},
  year = {2024},
  doi = {10.1016/j.ejim.2024.08.008}
}
Kostenlos starten →